BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nyssen A, Benhadou F, Magnée M, André J, Koopmansch C, Wautrecht JC. Chilblains. Vasa 2020;49:133-40. [PMID: 31808732 DOI: 10.1024/0301-1526/a000838] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Gerotziafas GT, Catalano M, Colgan MP, Pecsvarady Z, Wautrecht JC, Fazeli B, Olinic DM, Farkas K, Elalamy I, Falanga A, Fareed J, Papageorgiou C, Arellano RS, Agathagelou P, Antic D, Auad L, Banfic L, Bartolomew JR, Benczur B, Bernardo MB, Boccardo F, Cifkova R, Cosmi B, De Marchi S, Dimakakos E, Dimopoulos MA, Dimitrov G, Durand-Zaleski I, Edmonds M, El Nazar EA, Erer D, Esponda OL, Gresele P, Gschwandtner M, Gu Y, Heinzmann M, Hamburg NM, Hamadé A, Jatoi NA, Karahan O, Karetova D, Karplus T, Klein-Weigel P, Kolossvary E, Kozak M, Lefkou E, Lessiani G, Liew A, Marcoccia A, Marshang P, Marakomichelakis G, Matuska J, Moraglia L, Pillon S, Poredos P, Prior M, Salvador DRK, Schlager O, Schernthaner G, Sieron A, Spaak J, Spyropoulos A, Sprynger M, Suput D, Stanek A, Stvrtinova V, Szuba A, Tafur A, Vandreden P, Vardas PE, Vasic D, Vikkula M, Wennberg P, Zhai Z; Scientific Reviewer Committee. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost 2020;120:1597-628. [PMID: 32920811 DOI: 10.1055/s-0040-1715798] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
2 Maraj DC, Barak-Norris R. A Case of Longstanding Idiopathic Pernio/Chilblain Disease. Cureus 2021;13:e17674. [PMID: 34650852 DOI: 10.7759/cureus.17674] [Reference Citation Analysis]
3 Neri I, Virdi A, Corsini I, Guglielmo A, Lazzarotto T, Gabrielli L, Misciali C, Patrizi A, Lanari M. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown. J Eur Acad Dermatol Venereol 2020;34:2630-5. [PMID: 32533899 DOI: 10.1111/jdv.16751] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
4 El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection. J Eur Acad Dermatol Venereol 2020;34:2620-9. [PMID: 32474947 DOI: 10.1111/jdv.16682] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 32.0] [Reference Citation Analysis]
5 Zaladonis A, Huang S, Hsu S. COVID toes or pernio? Clin Dermatol 2020;38:764-7. [PMID: 33341212 DOI: 10.1016/j.clindermatol.2020.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Liu X, Gao YP, Shen ZX, Qu YY, Liu WW, Yao D, Xing B, Xu ZH, Li X, Zhao QC. Study on the experimental verification and regulatory mechanism of Rougui-Ganjiang herb-pair for the actions of thermogenesis in brown adipose tissue based on network pharmacology. J Ethnopharmacol 2021;279:114378. [PMID: 34192599 DOI: 10.1016/j.jep.2021.114378] [Reference Citation Analysis]
7 Seth S, Rashid F, Khera K. An overview of the COVID-19 complications in paediatric population: A pandemic dilemma. Int J Clin Pract 2021;75:e14494. [PMID: 34115913 DOI: 10.1111/ijcp.14494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Lo Y, Lin LY, Tsai TF. Use of calcium channel blockers in dermatology: a narrative review. Expert Rev Clin Pharmacol 2021;14:481-9. [PMID: 33612036 DOI: 10.1080/17512433.2021.1894128] [Reference Citation Analysis]
9 Ludzik J, Witkowski A, Hansel DE, Raess PW, White K, Leachman S. Case Report: Chilblains-like lesions (COVID-19 toes) during the pandemic - is there a diagnostic window? F1000Res 2020;9:668. [PMID: 32913640 DOI: 10.12688/f1000research.24766.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, Hernández-Martín Á, de la Torre-Espi M, Colmenero I, Torrelo A. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol 2020;37:406-11. [PMID: 32386460 DOI: 10.1111/pde.14215] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 49.0] [Reference Citation Analysis]
11 Kashetsky N, Mukovozov IM, Bergman J. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review. J Cutan Med Surg 2021;:12034754211004575. [PMID: 33849305 DOI: 10.1177/12034754211004575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Santos JN, de Brito Chagas J, Calvão J, Estanqueiro P, Ramos L. A severe case of chilblains in late 2020: Is there something else? J Paediatr Child Health 2021. [PMID: 34231278 DOI: 10.1111/jpc.15642] [Reference Citation Analysis]
13 Pande T, Agrawal A, Priya Ranjan. Penile Chill Blains: a Case Report. Indian J Surg 2021;:1-3. [PMID: 34054233 DOI: 10.1007/s12262-021-02959-z] [Reference Citation Analysis]
14 Weingarten M, Abittan B, Rivera-Oyola R, Abittan AI, Weingarten M, Lebwohl M. Treatment of COVID-19 induced chilblains with topical nitroglycerin. Int J Dermatol 2020;59:1522-4. [PMID: 33084032 DOI: 10.1111/ijd.15253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]